Susan L. Kelley's Net Worth

$940 Thousand

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is Susan L. Kelley?

Susan L. Kelley does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., Deciphera Pharmaceuticals, Inc., IDEAYA Biosciences, Inc., Dare Bioscience, Inc., and ARQULE INC.

SEC CIK

Susan L. Kelley's CIK is 0001519612

Past Insider Trading and Trends

2022 was Susan L. Kelley's most active year for acquiring shares with 5 total transactions. Susan L. Kelley's most active month to acquire stocks was the month of May. 2020 was Susan L. Kelley's most active year for disposing of shares, totalling 11 transactions. Susan L. Kelley's most active month to dispose stocks was the month of December. 2014 saw Susan L. Kelley paying a total of $60,160.00 for 80,000 shares, this is the most they've acquired in one year. In 2020 Susan L. Kelley cashed out on 255,000 shares for a total of $1,000,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNE DESIGN CORP. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 2
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jun 15
Form 3
—
0
—
—
0
No matching records found

Deciphera Pharmaceuticals, Inc. (DCPH) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jul 8
Form 3
—
0
—
—
0
No matching records found

IDEAYA Biosciences, Inc. (IDYA) Snapshot price: $36.21

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 9
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Feb 12
No matching records found

Dare Bioscience, Inc. (DARE) Snapshot price: $3.6

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jul 10
Form 4/A
—
0
—
—
0
Jul 19
Form 4
—
0
—
—
0
Jul 19
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 26
Form 4
—
0
—
—
0
Oct 3
Form 3
—
0
—
—
0
No matching records found

ARQULE INC No price found

Investor

Susan L. Kelley used to own units in Common Stock but no longer holds any shares there. From 2011 to 2020 Susan L. Kelley acquired a total of 50,000 shares in ARQULE INC at a cost of $60,160.00, Susan also disposed a total of 50,000 shares of ARQULE INC equalling to $1,000,000.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-50.00K
$20.00
-$1,000,000.00
0
Jan 16
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 11
Form 4
∞
50K
$1.20
$60,160.00
50K
Nov 13
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Apr 27
Form 3
—
0
—
—
0
No matching records found